Britain’s strong intellectual heritage in pharmaceuticals and bioscience, the receptive commercial environment fostered by the Pharmaceutical Price Regulation Scheme (PPRS), and a highly skilled workforce have, for many years, allowed the UK generally and the NHS in particular to benefit from modern pharmaceutical discovery and development.
Since 1948 – when the NHS was first set up – pharmaceutical companies have worked in a highly successful partnership with Government, policy makers and healthcare professionals to ensure that the most effective innovative medicines reach patients as quickly as possible.
For more than 60 years, this partnership has encouraged pharmaceutical research and development (R&D), manufacturing and marketing in the UK. In turn, the pharmaceutical sector’s increasing importance bolstered the economy, generated high-quality jobs, and supported local communities across the UK. The partnership has led to a remarkably successful R&D programme that has produced numerous medicines responsible for reducing mortality and morbidity, while enhancing quality of life for countless patients.
In the following sections you can find more information about these topics: